| __timestamp | Ascendis Pharma A/S | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 1860000 |
| Thursday, January 1, 2015 | 9415000 | 2963000 |
| Friday, January 1, 2016 | 11504000 | 6961000 |
| Sunday, January 1, 2017 | 13482000 | 11779000 |
| Monday, January 1, 2018 | 25057000 | 13697000 |
| Tuesday, January 1, 2019 | 48473000 | 15749000 |
| Wednesday, January 1, 2020 | 76669000 | 18638000 |
| Friday, January 1, 2021 | 160180000 | 27196000 |
| Saturday, January 1, 2022 | 221227000 | 31739000 |
| Sunday, January 1, 2023 | 264410000 | 33491000 |
| Monday, January 1, 2024 | 284545000 |
Unleashing insights
In the competitive world of biotechnology, effective cost management is crucial for success. Ascendis Pharma A/S and Protagonist Therapeutics, Inc. have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses over the past decade. Ascendis Pharma has seen a staggering increase of over 4,100% in SG&A expenses from 2014 to 2023, reflecting its aggressive growth strategy and expansion efforts. In contrast, Protagonist Therapeutics has maintained a more conservative approach, with a 1,700% increase over the same period. This divergence highlights the different strategic priorities of these companies, with Ascendis focusing on rapid scaling and Protagonist emphasizing steady growth. As the biotech industry continues to evolve, understanding these financial dynamics offers valuable insights into the operational strategies that drive success.
Takeda Pharmaceutical Company Limited vs Ascendis Pharma A/S: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc.
Breaking Down SG&A Expenses: Ascendis Pharma A/S vs Veracyte, Inc.
Ascendis Pharma A/S or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Alkermes plc or Protagonist Therapeutics, Inc.
PTC Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: MorphoSys AG vs Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Protagonist Therapeutics, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Dynavax Technologies Corporation
Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Celldex Therapeutics, Inc.